Bateman D N, Gorman D R, Bain M, Inglis J H C, House F R, Murphy D
NPIS Edinburgh (Scottish Poisons Information Bureau), Royal Infirmary of Edinburgh, Edinburgh, UK.
Br J Clin Pharmacol. 2006 Nov;62(5):573-81. doi: 10.1111/j.1365-2125.2006.02668.x.
To describe how changes in legislation to restrict paracetamol sales have affected overdose discharges and death associated with the drug in Scotland.
A descriptive analysis of routine death and hospital discharge data for the entire Scottish population between 1995 and 2004. Patients in Scotland participated who were discharged from hospital with a diagnosis of poisoning; deaths in Scotland from diagnosis of poisoning 1995-2003 were also analysed. Outcome measures were changes in mortality and overdose due to poisoning involving paracetamol. A comparison was made of in-hospital and out-of-hospital mortality in fatalities involving paracetamol.
The majority of paracetamol-associated deaths were due to co-proxamol. Deaths associated with paracetamol alone or with ethanol occurred principally in hospital and were a minority of deaths overall. The proportion of in-hospital deaths attributed to paracetamol increased (post/pre ratio 1.347; 95% confidence interval 1.076, 1.639; P = 0.013). Overall numbers of cases discharged with poisoning fell. The proportion of these involving paracetamol in any form increased significantly in all groups except young men aged 10 to <20 years.
Legislation has not reduced mortality or proportional use of paracetamol in overdose, both of which appear to have increased in Scotland since pack-size limitations. Other approaches are necessary to reduce the death rate from overdoses involving paracetamol.
描述苏格兰限制对乙酰氨基酚销售的立法变化如何影响与该药物相关的过量用药出院人数及死亡情况。
对1995年至2004年期间整个苏格兰人口的常规死亡和医院出院数据进行描述性分析。纳入苏格兰因中毒诊断而出院的患者;还分析了1995年至2003年苏格兰因中毒诊断导致的死亡情况。观察指标为涉及对乙酰氨基酚中毒的死亡率和过量用药情况的变化。对涉及对乙酰氨基酚死亡病例的院内和院外死亡率进行了比较。
大多数与对乙酰氨基酚相关的死亡是由复方丙氧氨酚所致。单独与对乙酰氨基酚或与乙醇相关的死亡主要发生在医院,且在总体死亡中占少数。归因于对乙酰氨基酚的院内死亡比例有所增加(后/前比值1.347;95%置信区间1.076, 1.639;P = 0.013)。因中毒出院的病例总数下降。除10至20岁以下的年轻男性外,所有组中涉及任何形式对乙酰氨基酚的比例均显著增加。
立法并未降低对乙酰氨基酚过量用药的死亡率或比例使用率,自包装尺寸限制以来,这两者在苏格兰似乎都有所增加。需要采取其他方法来降低涉及对乙酰氨基酚过量用药的死亡率。